MD3222G2 - Method of endometrial cancer diagnosis - Google Patents
Method of endometrial cancer diagnosisInfo
- Publication number
- MD3222G2 MD3222G2 MDA20060093A MD20060093A MD3222G2 MD 3222 G2 MD3222 G2 MD 3222G2 MD A20060093 A MDA20060093 A MD A20060093A MD 20060093 A MD20060093 A MD 20060093A MD 3222 G2 MD3222 G2 MD 3222G2
- Authority
- MD
- Moldova
- Prior art keywords
- endometrial cancer
- endometrial
- diagnosis
- cancer diagnosis
- determining
- Prior art date
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention refers to medicine, in particular to oncology and may be used for early noninvasive diagnosis and for endometrial cancer confirmation.Summary of the invention consists in determining the tryptophanhydroxylase-1 messenger RNA concentration in the endometrial and myometrial tissues, and in the case when in the endometrial tissue the concentration is 2…100 times greater, it is established the endometrial cancer diagnosis.The result of the invention consists in the possibility of early differential diagnosis of endometrial cancer for determining the pre- and postoperative efficient method of treatment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20060093A MD3222G2 (en) | 2006-03-22 | 2006-03-22 | Method of endometrial cancer diagnosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20060093A MD3222G2 (en) | 2006-03-22 | 2006-03-22 | Method of endometrial cancer diagnosis |
Publications (2)
Publication Number | Publication Date |
---|---|
MD3222F1 MD3222F1 (en) | 2007-01-31 |
MD3222G2 true MD3222G2 (en) | 2007-08-31 |
Family
ID=37776647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20060093A MD3222G2 (en) | 2006-03-22 | 2006-03-22 | Method of endometrial cancer diagnosis |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD3222G2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD3499G2 (en) * | 2007-10-12 | 2008-09-30 | Общественное Медико-Санитарное Учреждение Онкологический Институт | Method of differentiated treatment of endometrial cancer |
MD492Z (en) * | 2011-08-17 | 2012-10-31 | Лорена МЕДНИКОВ | Method for determining the spread of intestinal type gastric cancer |
-
2006
- 2006-03-22 MD MDA20060093A patent/MD3222G2/en not_active IP Right Cessation
Non-Patent Citations (9)
Title |
---|
H, Chen G, Zhang B. Expression of vascular endothelial growth factor and its receptors in endometrial carcinoma Zhonghua Bing Li Xue * |
Iwanari O, Miyako J, Date Y, Nakayama S, Kijima S, Moriyama M, Karino K, Endoh J, Kitao M.Clinical evaluations of the tumor marker sialyl * |
Iwanari O., Miyako J., Date Y., Nakayama S., Kijima S., Moriyama M., Karino K., Endoh J., Kitao M. Clinical evaluations of the tumor marker sialyl SSEA-1 antigen for clinical gynecological disease. Gynecol Obstet Invest. 1990, № 29, p. 214-218 * |
Jacobs I, Bast RC: The CA125 tumour-associated antigen: a review of the literature. * |
Jacobs I., Bast R. The CA125 tumour-associated antigen: a review of the literature. * |
SSEA-1 antigen for clinical gynecological disease. Gynecol Obstet Invest. 1990, № 29, p. 214-218 * |
Sung C., Zheng Y., Quddus M., Kang X., Zhang Z., Lauchlan S., Zheng W. P53 as a significant prognostic marker in endometrial carcinoma. Int J Gynecol Cancer. 2000 Mar, № 10(2), p. 119-127 * |
Sung CJ, Zheng Y, Quddus MR, Kang X, Zhang ZF, Lauchlan SC, Zheng W.p53 as a significant prognostic marker in endometrial carcinoma. Int * |
Wang H., Chen G., Zhang B. Expression of vascular endothelial growth factor and its receptors in endometrial carcinoma. Zhonghua Bing Li Xue Za Zhi. 2002, № 31(5), p. 391-395 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD3499G2 (en) * | 2007-10-12 | 2008-09-30 | Общественное Медико-Санитарное Учреждение Онкологический Институт | Method of differentiated treatment of endometrial cancer |
MD492Z (en) * | 2011-08-17 | 2012-10-31 | Лорена МЕДНИКОВ | Method for determining the spread of intestinal type gastric cancer |
Also Published As
Publication number | Publication date |
---|---|
MD3222F1 (en) | 2007-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LUC00011I2 (en) | ||
MX2007011545A (en) | Combinations for the treatment of cancer comprising anti-egfr antibody and vegfr inhibitors. | |
MY142067A (en) | Xanthine derivatives as selective hm74a agonists, processes for the manufacture of said derivatives, formulations comprising these derivatives, and their use in the treatment of diseases where under-activation of the hm74a receptor contributes to the disease | |
RS20150135A1 (en) | Treatment with anti-vegf antibodies | |
WO2004113571A3 (en) | Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis | |
HK1096392A1 (en) | Substituted heterocycles | |
MD3222G2 (en) | Method of endometrial cancer diagnosis | |
TW200806293A (en) | Methods of treatment with CETP inhibitors | |
WO2007110705A3 (en) | Macrolide as inhibitors of mhc class ii | |
WO2007110704A3 (en) | Macrolide compositions as therapeutic agent | |
WO2007146375A3 (en) | Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer | |
WO2007033096A3 (en) | Methods and compositions for diagnosis and treatment of disorders involving macrophages | |
MD3244G2 (en) | Method of determining the endometrial cancer aggressivity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |